North America leads in number of global pharma partnerships

Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019. According to new research, North America the highest amount of strategic pharma partnerships in the global pharmaceutical industry from 2014 to the first half of 2019. Within this time, over 1,300 separate strategic partnerships and 1,000 licensing agreements were made within pharma worldwide, reveals GlobalData. The industries investigated include gene therapy, immuno-oncology, microbiome and orphan drug therapeutics. The report details that North America had double the amount of partnerships than Europe and five times as many of the Asia-Pacific region within this time. This is suggested to be driven by US market prices. A further finding is that since 2018, the number of licenses in the Asia-Pacific region has begun to overtake those in Europe.